Literature DB >> 8816994

Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism.

P Chen1, H Xie, A Wells.   

Abstract

We recently demonstrated that epidermal growth factor receptor (EGFR)-mediated signaling of cell motility and mitogenesis diverge at the immediate post-receptor level. How these two mutually exclusive cell responses cross-communicate is not known. We investigated a possible role for a phospholipase C (PLC)-dependent feedback mechanism that attenuates EGF-induced mitogenesis. Inhibition of PLC gamma activation by U73122 (1 microM) augmented the EGF-induced [3H]thymidine incorporation by 23-55% in two transduced NR6 fibroblast lines expressing motility-responsive EGFR; increased cell division and mitosis was observed in parallel. The time dependence of this increase revealed that it was due to an increase in maximal incorporation and not a foreshortened cell cycle. Motility-responsive cell lines expressing a dominant-negative PLC gamma fragment (PLCz) also demonstrated augmented mitogenic responses by 25-68% when compared with control cells. PLCz- or U73122-augmented mitogenesis was not observed in three non-PLC gamma activating, nonmotility-responsive EGFR-expressing cell lines. Protein kinase C (PKC), which may be activated by PLC-generated second messengers, has been proposed as mediating feedback attenuation due to its capacity to phosphorylate EGFR and inhibit the receptor's tyrosine kinase activity. Inhibition of PKC by Calphostin C (0.05 microM) resulted in a 57% augmentation in the fold of EGF-induced thymidine incorporation. To further establish PKC's role in this feedback attenuation mechanism, an EGFR point mutation, in which the PKC target threonine654 was replaced by alanine, was expressed. Cells expressing these PKC-resistant EGFR constructs demonstrated EGF-induced motility comparable to cells expressing the threonine-containing EGFR. However, when these cells were treated with U73122 or Calphostin C, the mitogenic responses are not enhanced. These findings suggest a model in which PKC activation subsequent to triggering of motility-associated PLC gamma activity attenuates the EGFR mitogenic response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816994      PMCID: PMC275939          DOI: 10.1091/mbc.7.6.871

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  40 in total

1.  EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling.

Authors:  B Margolis; S G Rhee; S Felder; M Mervic; R Lyall; A Levitzki; A Ullrich; A Zilberstein; J Schlessinger
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

2.  Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation.

Authors:  K A Lund; C S Lazar; W S Chen; B J Walsh; J B Welsh; J J Herbst; G M Walton; M G Rosenfeld; G N Gill; H S Wiley
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

3.  EGF receptor activities in mammalian development.

Authors:  E D Adamson
Journal:  Mol Reprod Dev       Date:  1990-09       Impact factor: 2.609

4.  Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils.

Authors:  J E Bleasdale; N R Thakur; R S Gremban; G L Bundy; F A Fitzpatrick; R J Smith; S Bunting
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

5.  Differential induction of phosphatidylcholine hydrolysis, diacylglycerol formation and protein kinase C activation by epidermal growth factor and transforming growth factor-alpha in normal human skin fibroblasts and keratinocytes.

Authors:  N J Reynolds; H S Talwar; J J Baldassare; P A Henderson; J T Elder; J J Voorhees; G J Fisher
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

6.  Effect of phospholipase C-gamma overexpression on PDGF-induced second messengers and mitogenesis.

Authors:  B Margolis; A Zilberstein; C Franks; S Felder; S Kremer; A Ullrich; S G Rhee; K Skorecki; J Schlessinger
Journal:  Science       Date:  1990-05-04       Impact factor: 47.728

7.  Constitutive phosphorylation of the epidermal growth factor receptor blocks mitogenic signal transduction.

Authors:  S Bowen; K Stanley; E Selva; R J Davis
Journal:  J Biol Chem       Date:  1991-01-15       Impact factor: 5.157

8.  Regulation of surface expression of high-affinity receptors for epidermal growth factor (EGF) in hepatocytes by hormones, differentiating agents, and phorbol ester.

Authors:  I P Gladhaug; M Refsnes; T Christoffersen
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

9.  Prostaglandin F2 alpha decreases the affinity of epidermal growth factor receptors in Swiss mouse 3T3 cells via protein kinase C activation.

Authors:  L Jimenez de Asua; M Goin
Journal:  FEBS Lett       Date:  1992-03-16       Impact factor: 4.124

10.  A negative feedback loop attenuates EGF-induced morphological changes.

Authors:  J B Welsh; G N Gill; M G Rosenfeld; A Wells
Journal:  J Cell Biol       Date:  1991-08       Impact factor: 10.539

View more
  34 in total

1.  Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration.

Authors:  D H Wolf; S Numan; E J Nestler; D S Russell
Journal:  J Neurochem       Date:  1999-10       Impact factor: 5.372

2.  Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation.

Authors:  K Elenius; S Paul; G Allison; J Sun; M Klagsbrun
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 3.  Post-translational modifications in signal integration.

Authors:  Yonathan Lissanu Deribe; Tony Pawson; Ivan Dikic
Journal:  Nat Struct Mol Biol       Date:  2010-05-23       Impact factor: 15.369

4.  Sequential activation of phoshatidylinositol 3-kinase and phospholipase C-gamma2 by the M-CSF receptor is necessary for differentiation signaling.

Authors:  R P Bourette; G M Myles; J L Choi; L R Rohrschneider
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

5.  Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain.

Authors:  Hidenori Shiraha; Angela Glading; Jeffrey Chou; Zongchao Jia; Alan Wells
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

6.  EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells.

Authors:  T Turner; P Chen; L J Goodly; A Wells
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

7.  MAPK scaffold IQGAP1 binds the EGF receptor and modulates its activation.

Authors:  Dean E McNulty; Zhigang Li; Colin D White; David B Sacks; Roland S Annan
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

8.  Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells.

Authors:  Amandine Hurbin; Jean-Luc Coll; Laurence Dubrez-Daloz; Bernard Mari; Patrick Auberger; Christian Brambilla; Marie-Christine Favrot
Journal:  J Biol Chem       Date:  2005-03-14       Impact factor: 5.157

9.  Differential signaling of the GnRH receptor in pituitary gonadotrope cell lines and prostate cancer cell lines.

Authors:  Ludmila Sviridonov; Masha Dobkin-Bekman; Boris Shterntal; Fiorenza Przedecki; Linor Formishell; Shani Kravchook; Liat Rahamim-Ben Navi; Tali Hana Bar-Lev; Marcelo G Kazanietz; Zhong Yao; Rony Seger; Zvi Naor
Journal:  Mol Cell Endocrinol       Date:  2013-02-01       Impact factor: 4.102

10.  TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis.

Authors:  D Perrotti; S Bonatti; R Trotta; R Martinez; T Skorski; P Salomoni; E Grassilli; R V Lozzo; D R Cooper; B Calabretta
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.